Ipca Laboratories Limited (NSE:IPCALAB)

Ipca Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,672	2,089	12,579	2,752	1,660
Short-Term Investments	1,745	851.3	5,950	3,657	1,991
Trading Asset Securities	7,634	5,584	3,233	7,193	3,938
Cash & Short-Term Investments	11,051	8,524	21,761	13,602	7,589
Cash Growth	29.63%	-60.83%	59.98%	79.24%	81.61%
Accounts Receivable	18,841	16,946	9,961	9,180	8,157
Other Receivables	2,568	2,012	1,865	2,088	1,958
Receivables	21,837	19,052	11,859	11,372	10,128
Inventory	25,604	24,713	17,434	18,580	15,948
Prepaid Expenses	573.1	482.9	311.9	188.6	187.4
Other Current Assets	3,620	2,617	527.1	829.7	517.7
Total Current Assets	62,685	55,389	51,893	44,572	34,370
Property, Plant & Equipment	46,851	46,631	26,946	25,026	21,465
Long-Term Investments	2,163	3,036	3,027	2,699	1,114
Goodwill	905.8	905.8	381.4	388.4	466
Other Intangible Assets	1,127	1,426	1,591	1,672	1,142
Long-Term Deferred Tax Assets	169.2	42.3	35.7	20.2	19.5
Other Long-Term Assets	3,381	2,697	1,232	1,144	1,294
Total Assets	117,606	111,013	86,264	76,235	60,684
Accounts Payable	8,462	7,761	5,251	5,577	6,649
Accrued Expenses	3,216	3,800	2,051	2,278	499.3
Short-Term Debt	4,953	5,592	6,618	3,678	1,766
Current Portion of Long-Term Debt	2,632	2,479	1,439	282.5	666
Current Portion of Leases	101.4	109.3	66.6	44.8	48
Current Income Taxes Payable	575	462	253.2	183.3	114.4
Current Unearned Revenue	154.7	168.7	274	267.7	208.5
Other Current Liabilities	3,769	3,184	2,105	2,347	1,655
Total Current Liabilities	23,862	23,556	18,058	14,659	11,605
Long-Term Debt	5,432	5,804	6,518	3,952	91.3
Long-Term Leases	509	399.3	170.8	115	82.5
Long-Term Unearned Revenue	-	1.2	2.8	4.3	5.9
Long-Term Deferred Tax Liabilities	2,950	3,105	1,892	1,644	1,336
Other Long-Term Liabilities	850	787.4	453.2	430.1	389.9
Total Liabilities	33,723	33,743	27,111	20,818	13,522
Common Stock	253.7	253.7	253.7	253.7	253.7
Additional Paid-In Capital	965.2	965.2	965.2	965.2	965.2
Retained Earnings	68,424	62,104	57,151	53,471	45,588
Comprehensive Income & Other	-158.2	-1	50.7	-41.6	209.6
Total Common Equity	69,485	63,322	58,420	54,648	47,017
Minority Interest	14,398	13,948	733	769.2	145.3
Shareholders' Equity	83,883	77,270	59,153	55,418	47,162
Total Liabilities & Equity	117,606	111,013	86,264	76,235	60,684
Total Debt	13,627	14,384	14,813	8,072	2,654
Net Cash (Debt)	-2,577	-5,859	6,949	5,530	4,935
Net Cash Growth	-	-	25.65%	12.06%	-
Net Cash Per Share	-10.16	-23.09	27.39	21.80	19.48
Filing Date Shares Outstanding	253.7	253.7	253.7	253.7	253.7
Total Common Shares Outstanding	253.7	253.7	253.7	253.7	253.7
Working Capital	38,823	31,833	33,835	29,913	22,764
Book Value Per Share	273.88	249.59	230.27	215.40	185.32
Tangible Book Value	67,452	60,990	56,448	52,588	45,409
Tangible Book Value Per Share	265.87	240.40	222.49	207.28	178.98
Land	3,075	6,425	2,145	2,157	2,102
Buildings	14,432	13,569	8,175	7,140	6,090
Machinery	46,700	43,737	29,454	24,473	21,219
Construction In Progress	6,162	3,236	1,222	2,939	1,837
Leasehold Improvements	-	-	7.9	-	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.